CLX Stock Update: JP Morgan Adjusts Clorox Price Target | CLX Stock News

Author's Avatar
May 06, 2025
Article's Main Image

On May 6, 2025, JP Morgan analyst Andrea Teixeira made adjustments to the price target for Clorox (CLX, Financial). The new price target stands at USD 144.00, down from the previous estimation of USD 151.00. This change represents a decrease of approximately 4.64% in the price target.

Despite this adjustment in the price target, JP Morgan maintains its current "Neutral" rating for Clorox (CLX, Financial). The rating remains unchanged from its previous status.

These updates are indicative of JP Morgan's latest evaluation of Clorox (CLX, Financial) as the stock continues to be monitored closely by market participants and analysts alike.

Wall Street Analysts Forecast

1919733040570068992.png

Based on the one-year price targets offered by 17 analysts, the average target price for Clorox Co (CLX, Financial) is $154.42 with a high estimate of $189.00 and a low estimate of $134.00. The average target implies an upside of 11.58% from the current price of $138.39. More detailed estimate data can be found on the Clorox Co (CLX) Forecast page.

Based on the consensus recommendation from 21 brokerage firms, Clorox Co's (CLX, Financial) average brokerage recommendation is currently 3.0, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Based on GuruFocus estimates, the estimated GF Value for Clorox Co (CLX, Financial) in one year is $148.31, suggesting a upside of 7.17% from the current price of $138.39. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Clorox Co (CLX) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.